Howard Aizenstein, MD, PhD, Professor of Psychiatry and Associate Professor of Bioengineering, and Clinical and Translational Science, University of Pittsburgh School of Medicine
Course Objectives:
♦Apply data-supported pharmacologic management strategies including the roles, cautions and potential alternatives to using cholinesterase inhibitors, memantine, antipsychotics, and
antidepressants in ADRD.
♦ Apply data-supported strategies to identify and minimize the use of anticholinergic agents in
patients with ADRD.
♦ Understand the future clinical care: implications of research on AD biomarkers and clinical trials.
Program is approved for CE’s in PA
♦1.5 Medicine & Nursing
♦ 1.5 for PA L/CSW, LPC, LMFT, Psychology*
No cost for the first 50 professional registrants; $25 for all others
♦SW, LPC, LMFT, & Psych participants must have completed the March 9 program on Assessment of ADRD in series to earn 3 CEs (1.5 for this one and 1.5 for previous one).
No Registration Fee Required